<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4798">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04461769</url>
  </required_header>
  <id_info>
    <org_study_id>R44MH115955</org_study_id>
    <nct_id>NCT04461769</nct_id>
  </id_info>
  <brief_title>Electrical Synchronization of Slow Oscillations to Enhance Deep Sleep</brief_title>
  <acronym>ESSOTEDS</acronym>
  <official_title>Electrical Synchronization of Slow Oscillations to Enhance Deep Sleep</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brain Electrophysiology Laboratory Company</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brain Electrophysiology Laboratory Company</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study applied slowly oscillating (0.5 hz) transcranial electrical stimulation (TES;&#xD;
      frontopolar and lateral frontal electrodes versus mastoid and occipital electrode returns) to&#xD;
      synchronize the endogenous slow oscillations (SOs) of deep sleep (N3 or stage 3 Non-REM). A&#xD;
      double-blind placebo control provided no stimulation. The primary endpoint was duration of N3&#xD;
      sleep during the night. Thirteen normal adults completed the study (before the study was&#xD;
      terminated because of COVID-19), and usable data were obtained from ten. The synchronizing&#xD;
      stimulation resulted in significantly longer N3 sleep compared to placebo.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Previous studies have demonstrated successful synchronization of SOs with slow TES pulses.&#xD;
      However, the stimulation in those studies used electrodes in dorsolateral frontal areas (F3,&#xD;
      F4 versus contralateral mastoids), consistent with the assumption that human SOs emanate from&#xD;
      frontal neocortex. In the present study, we hypothesized that transcranial electrical&#xD;
      stimulation (TES) could be applied to frontopolar and inferior frontal head sites in order to&#xD;
      synchronize the limbic sources of SOs specifically and thereby enhance the duration of N3&#xD;
      sleep. Furthermore, based on our computational modeling with this more optimal targeting of&#xD;
      the limbic sites, we hypothesized that we could use lower TES current levels (0.5 mA versus 1&#xD;
      or 2 mA in previous studies) that would be unlikely to disrupt sleep and that may still be&#xD;
      successful in synchronizing SOs to enhance the adaptive neurophysiology of deep sleep.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2019</start_date>
  <completion_date type="Actual">May 30, 2020</completion_date>
  <primary_completion_date type="Actual">May 30, 2020</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>First night adaptation sleep; second and third nights (one week apart) stimulation or placebo control (order randomized).</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>Participants were blind to which night was stimulation. Experimenters were blinded until the participant was asleep, when they opened an email that specified delivery of stimulation or sham.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>N3 Duration</measure>
    <time_frame>Measured during the night of sleep (typically 8 hours)</time_frame>
    <description>Duration in minutes of N3 sleep</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>N3 Percentage</measure>
    <time_frame>Measured during the night of sleep (typically 8 hours)</time_frame>
    <description>Percentage of the night's sleep spent in N3</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Sleep</condition>
  <condition>Sleep Hygiene</condition>
  <arm_group>
    <arm_group_label>Slow Oscillation Synchronization with TES</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transcranial Electrical Stimulation, 0.5 Hz sine wave, 0.5 mA, between frontal (frontopolar and inferior lateral frontal) and posterior (mastoid and occipital) electrodes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>No current delivered.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial Electrical Stimulation</intervention_name>
    <description>Oscillating electrical current</description>
    <arm_group_label>Sham Control</arm_group_label>
    <arm_group_label>Slow Oscillation Synchronization with TES</arm_group_label>
    <other_name>Sleep WISP (Wireless Interface Sensor Pod)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        -&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  history of seizures&#xD;
&#xD;
          -  epilepsy&#xD;
&#xD;
          -  brain trauma or injury&#xD;
&#xD;
          -  insomnia&#xD;
&#xD;
          -  sleep apnea&#xD;
&#xD;
          -  medications that may affect the EEG.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Brain Electrophysiology Laboratory Company</name>
      <address>
        <city>Eugene</city>
        <state>Oregon</state>
        <zip>97405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>June 30, 2020</study_first_submitted>
  <study_first_submitted_qc>July 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 8, 2020</study_first_posted>
  <last_update_submitted>July 2, 2020</last_update_submitted>
  <last_update_submitted_qc>July 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

